Skip Nav Destination
Global Hematology Commentary|
August 23, 2025
Real-World Ibrutinib in CLL: Efficacy, Tolerability, Access Open Access
Ángel Serna
Ángel Serna
https://orcid.org/0000-0001-7532-9634
Search for other works by this author on:
Blood Global Hematology 100027.
Article history
Submitted:
July 31, 2025
Accepted:
August 3, 2025
